Skip to main content
Signal8

WALLER GREGORY D

SEC insider (Form 3/4/5 filer). CIK 0001204144. Director at Arcadia Biosciences, Inc. (RKDA) and 1 other issuer. 3 reported Form 4/5 transactions since Sep 2024; latest on Sep 10, 2026. Located in DALLAS, TX.

Companies WALLER GREGORY D has filed insider reports for

  • Arcadia Biosciences, Inc. (RKDA): Director
  • Nuwellis, Inc. (NUWE): Director
WALLER GREGORY D profile photo

WALLER GREGORY D

CIK: 0001204144

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Arcadia Biosciences, Inc. logo
RKDA

Arcadia Biosciences, Inc.

Director
Nuwellis, Inc. logo
NUWE

Nuwellis, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Arcadia Biosciences, Inc. logo
    RKDA

    Arcadia Biosciences, Inc.

    Sep 10, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    10K shares-
  • Nuwellis, Inc. logo
    NUWE

    Nuwellis, Inc.

    Apr 28, 2026
    Award

    Nonstatutory Stock Option (right to buy)

    Direct
    6.7K shares-
  • Nuwellis, Inc. logo
    NUWE

    Nuwellis, Inc.

    May 20, 2025
    Award

    Nonstatutory Stock Option (right to buy)

    Direct
    17.5K shares-

1-3 of 3